Evidence map›Paper›PMID 34806003›Full record

ArticleJAC-antimicrobial resistance2021

Genetic analysis of plasmid-encoded

Casper Jamin, Bazante K Sanders, Miaomiao Zhou, Adalberto Costessi, Danny Duijsings, Jan A J W Kluytmans, Lieke B van Alphen, Eefje J A Schrauwen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Article
  4. Mobile colistin resistanceJAC-antimicrobial resistance · 2023
    Article
  5. Occurrence ofFrontiers in microbiology · 2022
    Article
  6. Spread of theFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Casper JaminDepartment of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center, Maastricht, The Netherlands.
Bazante K SandersAcademy for Technology of Health and Environment, Avans University of Applied Science, Breda, The Netherlands.
Miaomiao ZhouAcademy for Technology of Health and Environment, Avans University of Applied Science, Breda, The Netherlands.
Adalberto CostessiBaseClear B.V., Leiden, The Netherlands.
Danny DuijsingsBaseClear B.V., Leiden, The Netherlands.
Jan A J W KluytmansDepartment of Infection Control, Amphia Hospital, Breda, The Netherlands.
Lieke B van AlphenDepartment of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center, Maastricht, The Netherlands.
Eefje J A SchrauwenAcademy for Technology of Health and Environment, Avans University of Applied Science, Breda, The Netherlands.
Avans University of Applied Sciences · NLBioclear Earth (Netherlands) · NLMaastricht University · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColistin is classified as the highest priority and critically important antimicrobial for human medicine by WHO as it is the last resort agent for treatment of carbapenem-resistant Enterobacteriaceae in humans. Additional research is necessary to elucidate the genetic structure of

objectivesTo map and compare the genetic characteristics of 35

methodsSequencing was performed using Illumina HiSeq2500, Novaseq6000 and ONT's GridION. GridION data was locally basecalled and demultiplexed using ONT's Albacore 2.3.4 followed by Porechop 2.3. Quality filtering was performed using Filtlong 2.0. Hybrid Assembly was performed using Unicycler 4.7. Plasmids were compared with reference sequences in plasmid-RefSeq and pATLAS.

resultsA total of 35

conclusionsThe

Identifiers

PMID34806003
PMCPMC8597959
OpenAlexW3214435964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.